138 related articles for article (PubMed ID: 37058821)
1. Systemic exposure of floxuridine after hepatic arterial infusion pump chemotherapy with floxuridine in patients with resected colorectal liver metastases.
IJzerman NS; Filipe WF; Bruijn P; Buisman FE; Doorn LV; Doornebosch PG; Holster JJ; Grootscholten C; Grünhagen DJ; van Bommel CPE; Homs MYV; Kok NFM; Verhoef C; Koerkamp BG; Kuhlmann KFD; Mathijssen RHJ; Koolen SLW
Biomed Pharmacother; 2023 Jun; 162():114625. PubMed ID: 37058821
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
[TBL] [Abstract][Full Text] [Related]
3. Hepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases: Outcomes in a newly established program.
Walker BS; Billingsley KG; Sutton TL; Kolbeck KJ; Korngold EK; Nabavizadeh N; Dewey EN; Herzig DO; Lopez CD; Mayo SC
J Surg Oncol; 2022 Sep; 126(3):513-522. PubMed ID: 35522249
[TBL] [Abstract][Full Text] [Related]
4. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.
Kemeny N; Seiter K; Conti JA; Cohen A; Bertino JR; Sigurdson ER; Botet J; Chapman D; Mazumdar M; Budd AJ
Cancer; 1994 Feb; 73(4):1134-42. PubMed ID: 8313315
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic chemotherapy with floxuridine, leucovorin and dexamethasone in continuous infusion and mitomycin-C bolus in unresectable hepatic metastases from colorectal cancer: a phase II study.
Bertuccelli M; Falcone A; Campoccia S; Conti M; Brunetti I; Caramella D; Giulianotti PC; Mosca F; Bartolozzi C; Conte PF
Tumori; 1999; 85(6):473-7. PubMed ID: 10774568
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands.
Buisman FE; Grünhagen DJ; Homs MYV; Grootscholten C; Filipe WF; Kemeny NE; Cercek A; D'Angelica MI; Donswijk ML; van Doorn L; Emmering J; Jarnagin WR; Kingham TP; Klompenhouwer EG; Kok NFM; Kuiper MC; Moelker A; Prevoo W; Versleijen MWJ; Verhoef C; Kuhlmann KFD; Groot Koerkamp B
Ann Surg Oncol; 2019 Dec; 26(13):4599-4607. PubMed ID: 31641947
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma.
Franssen S; Soares KC; Jolissaint JS; Tsilimigras DI; Buettner S; Alexandrescu S; Marques H; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Margonis GA; Weiss MJ; Bauer TW; Shen F; Poultsides GA; Marsh JW; Cercek A; Kemeny N; Kingham TP; D'Angelica M; Pawlik TM; Jarnagin WR; Koerkamp BG
JAMA Surg; 2022 Jul; 157(7):590-596. PubMed ID: 35544131
[TBL] [Abstract][Full Text] [Related]
8. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
Kemeny N; Huang Y; Cohen AM; Shi W; Conti JA; Brennan MF; Bertino JR; Turnbull AD; Sullivan D; Stockman J; Blumgart LH; Fong Y
N Engl J Med; 1999 Dec; 341(27):2039-48. PubMed ID: 10615075
[TBL] [Abstract][Full Text] [Related]
9. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer.
Kemeny N; Jarnagin W; Gonen M; Stockman J; Blumgart L; Sperber D; Hummer A; Fong Y
J Clin Oncol; 2003 Sep; 21(17):3303-9. PubMed ID: 12947066
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer.
Kemeny N; Capanu M; D'Angelica M; Jarnagin W; Haviland D; Dematteo R; Fong Y
Ann Oncol; 2009 Jul; 20(7):1236-41. PubMed ID: 19233901
[TBL] [Abstract][Full Text] [Related]
11. Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases.
Chakedis J; Beal EW; Sun S; Galo J; Chafitz A; Davidson G; Reardon J; Dillhoff M; Pawlik TM; Abdel-Misih S; Bloomston M; Schmidt CR
J Surg Oncol; 2018 Dec; 118(7):1065-1073. PubMed ID: 30376157
[TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy for borderline resectable and unresectable colorectal liver metastases: phase II feasibility study.
Krul MF; Kok NFM; Osmani H; Buisman FE; Groot Koerkamp B; Grunhagen DJ; Verhoef C; Mostert B; Snaebjornsson P; Westerink B; Klompenhouwer EG; Donswijk ML; Ruers TJM; Douma JAJ; van Blijderveen N; Kingham TP; D'Angelica MI; Kemeny NE; Bolhuis K; Buffart TE; Kuhlmann KFD
Br J Surg; 2024 Apr; 111(4):. PubMed ID: 38608150
[TBL] [Abstract][Full Text] [Related]
13. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver.
Martin RC; Edwards MJ; McMasters KM
Am J Surg; 2004 Dec; 188(6):714-21. PubMed ID: 15619489
[TBL] [Abstract][Full Text] [Related]
14. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
15. Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma.
Kemeny N; Cohen A; Bertino JR; Sigurdson ER; Botet J; Oderman P
Cancer; 1990 Jun; 65(11):2446-50. PubMed ID: 2140070
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases.
Kemeny N; Conti JA; Sigurdson E; Cohen A; Seiter K; Lincer R; Niedzwiecki D; Botet J; Chapman D; Costa P
Cancer; 1993 Mar; 71(6):1964-71. PubMed ID: 8443746
[TBL] [Abstract][Full Text] [Related]
17. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G
Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951
[TBL] [Abstract][Full Text] [Related]
18. Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
Holster JJ; El Hassnaoui M; Franssen S; IJzermans JNM; de Jonge J; Mostert B; Polak WG; de Wilde RF; Homs MYV; Groot Koerkamp B
Ann Surg Oncol; 2022 Sep; 29(9):5528-5538. PubMed ID: 35294656
[TBL] [Abstract][Full Text] [Related]
19. Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study.
Muaddi H; D'Angelica M; Wiseman JT; Dillhoff M; Latchana N; Roke R; Ko YJ; Carpizo D; Spencer K; Fields RC; Williams G; Aucejo F; Acevedo-Moreno LA; Billingsley KG; Walker BS; Mayo SC; Karanicolas PJ
J Surg Oncol; 2021 Jan; 123(1):252-260. PubMed ID: 33095919
[TBL] [Abstract][Full Text] [Related]
20. Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion.
Focan C; Levi F; Kreutz F; Focan-Henrard D; Lobelle JP; Adam R; Dallemagne B; Jehaes C; Markiewicz S; Weerts J; Bismuth H; Jasmin C; Misset JL
Anticancer Drugs; 1999 Apr; 10(4):385-92. PubMed ID: 10378673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
